• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OIL

OPTISCAN IMAGING LIMITED - News & Media

0.00% ! 10.5¢
Market Cap $87.71M  !
Healthcare Medical Devices
Add to My Watchlist

Optiscan Imaging Limited is an Australia-based company, which is engaged in the... Optiscan Imaging Limited is an Australia-based company, which is engaged in the development, manufacturing and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. The Company’s technology enables real-time, non-destructive, three-dimensional (3D), in-vivo imaging at the single-cell level. It provides real-time microscopic imaging tools to healthcare providers and researchers to enable the early detection and management of disease. Its InVivage device is an intra-oral digital microscope that offers the power of single-cell oral imaging at your fingertips in the palm of your hand. Its ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Articles & Videos

Optiscan starts German trial to test imaging capability on gastrointestinal tract

Optiscan Imaging Ltd has begun a pre-clinical trial in Mainz, Germany, which involves completion of a prototype to collect images

03 Feb 2025 10:09 (AEDT)

Optiscan's unveils InVue for better insights and decision-making during surgery

Optiscan has unveiled InVue,  a new microscopic medical imaging device designed to enable precision surgery by putting real-time digital pathology into the hands of surgeons.

04 Jun 2024 14:28 (AEST)

Optiscan agreement with Mayo Clinic aims to expedite robotic surgery

Optiscan Imaging is parterning with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system

13 May 2024 14:10 (AEST)

Optiscan Imaging's (ASX:OIL) technology proven "extremely accurate" for oral cancer diagnosis

A recent Optiscan Imaging (ASX:OIL) study has demonstrated the company's technology to be “extremely accurate” for the diagnosis of oral cancer and precancer.

14 Mar 2023 10:29 (AEDT)

Optiscan Imaging (ASX:OIL) partners with Prolucid to develop AI-based cancer detection tech

Optiscan Imaging (ASX:OIL) has partnered with software developer Prolucid Technologies to develop artificial intelligence (AI) algorithms and telepathology workflows.

30 Jan 2023 12:51 (AEDT)



Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
10.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $87.71M
Open High Low Value Volume
10.5¢ 10.5¢ 10.5¢ $631 6.005K

Buyers (Bids)

No. Vol. Price($)
3 79609 10.5¢
 

Sellers (Offers)

Price($) Vol. No.
11.5¢ 5840 1
View Market Depth
Last trade - 13.53pm 30/07/2025 (20 minute delay) ?
OIL (ASX) Chart

Top Stories

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

The ASX200 rebounded today and was in the green heading into the close. Investors were buoyant in response to positive inflation data that increased the odds of an interest rate cut in August.Staples, Real Estate and Discretionary were the strongest performing sectors. Utilities and IT were a dra...
Haranga jumps +7% on Lincoln acquisition Haranga Resources (ASX:HAR) has spiked in intra-day trade after closing the acquisition of the Lincoln Gold Project in California.The Lincoln Project traverses 322 hectares and covers a strike length of the Mother Lode with 5.8km between Sutter Creek and Amador City. It boasts a gold resource of ...
Neurizon inks $1.5M loan against R&D Tax Rebate Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic Let’s check in with what HotCopper users are closely watching at lunchtime. Given that we’re basically on the deadline before companies get a scolding if they don’t report updates, on Wednesday, the ASX announcements list is basically one big wall o...
Ionic Rare Earths falls -7% as momentum slips on vague production update Ionic Rare Earths (ASX:IXR) @ a well-known and much-loved rare earths darling on something of a comeback run lately @ has slipped -7%, presumably as the market digests what a vague update released on Wednesday actually means. According to the company, @urgent supply requests from US, European and...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.